Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic proliferation inhibitor.

P T Iype, J B McMahon

    Molecular and Cellular Biochemistry
    |January 1, 1984
    PubMed
    Summary

    Researchers purified a homogenous hepatic proliferation inhibitor that specifically blocks cell division and DNA synthesis in non-malignant liver cells. This discovery advances understanding of endogenous inhibitors

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Legacy of Multiple Stressors: Responses of Gastropod Larvae and Juveniles to Ocean Acidification and Nutrition.

    The Biological bulletin·2019
    Same author

    Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation.

    Cell death & disease·2015
    Same author

    Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.

    Journal of medical primatology·2007
    Same author

    Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner.

    Molecular pharmacology·2001
    Same author

    Development of a cyanovirin-N-HIV-1 gp120 binding assay for high throughput screening of natural product extracts by time-resolved fluorescence.

    Journal of biomolecular screening·2000
    Same author

    The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding.

    Biochemical and biophysical research communications·1998

    Area of Science:

    • Cell Biology
    • Molecular Biology
    • Biochemistry

    Background:

    • Endogenous inhibitors are known to modulate cell proliferation, but purification has been challenging.
    • Previous studies identified hepatic proliferation inhibitors of varying purity from rat liver and serum.
    • Lack of homogenous inhibitors hindered precise mechanistic studies of cell cycle regulation.

    Purpose of the Study:

    • To purify a homogenous hepatic proliferation inhibitor.
    • To characterize its properties and mechanism of action.
    • To investigate its specific effects on different cell types.

    Main Methods:

    • Utilized well-characterized, non-malignant rat liver diploid epithelial cell cultures.
    • Purified a hepatic proliferation inhibitor to homogeneity.
    • Assessed effects on cell division, DNA synthesis, and cell cycle phase in various cell types.

    Main Results:

    • A homogenous protein inhibitor with a molecular weight of 26,000 daltons and pI of 4.65 was purified.
    • The inhibitor specifically blocked cell division and DNA synthesis in non-malignant rat liver epithelial cells.
    • No effect was observed on transformed liver cells or hepatoma cells; cells were primarily arrested in the G1 phase.

    Conclusions:

    • A homogenous hepatic proliferation inhibitor has been successfully isolated and characterized.
    • This inhibitor selectively targets non-malignant liver cells, offering a specific tool for studying cell cycle control.
    • Further research will explore its precise mechanism of action and relationship to other cell cycle regulatory pathways.

    Related Experiment Videos